Leucadia National Corporation »

Sarepta Therapeutics note 1.500% 11/1 shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Sarepta Therapeutics note 1.500% 11/1 shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Sarepta Therapeutics note 1.500% 11/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics note 1.500% 11/1 held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics note 1.500% 11/1 by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $196k 140k 1.40
2023-09-30 $256k 144k 1.78
2023-06-30 $234k 138k 1.69
2023-03-31 $56k 29k 1.93
2022-12-31 $34k 18k 1.87

More positions owned by Leucadia National Corporation

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Walt Disney Company (DIS)
Spdr Gold Tr Gold Shs (GLD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Russell 2000 Etf (IWM)
Delta Air Lines Inc Del Com New (DAL)
Visa Com Cl A (V)
Uber Technologies (UBER)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Micron Technology (MU)
Spdr Ser Tr S&p Biotech (XBI)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Hillman Solutions Corp (HLMN)

View all positions for Leucadia National Corporation

Top funds holding Sarepta Therapeutics note 1.500% 11/1

DLD Asset Management
Point72 Asset Management
D. E. Shaw & Co
CSS
Capstone Investment Advisors
Boothbay Fund Management
FMR
Warberg Asset Management
Palisade Capital Management
Wolverine Asset Management
Bnp Paribas Arbitrage, Snc
Morgan Stanley
Fox Hill Wealth Management
Virtus Investment Advisers
Jpmorgan Chase & Co

View all funds holding Sarepta Therapeutics note 1.500% 11/1